Eddy M. Sotelo
Santiago De Compostela, GA 15782, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Discovery of bridged melanostatin derivatives as potent allosteric modulators of the dopamine D2 receptors with improved permeability.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 11, 2026
Discovery of first-in-class melanostatin-based ago-allosteric modulators of the dopamine D2 receptors.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 20, 2025
Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB2 Agonists with Neuroprotective Effects.
Journal: Journal of medicinal chemistry
Published: August 12, 2025
Targeting the adenosinergic axis in cancer immunotherapy: Insights into A2A and A2B receptors and novel clinical combination strategies.
Journal: Pharmacological reviews
Published: June 19, 2025
Cannabinoid CB1 Receptor Activation Mitigates N‑Methyl‑d‑aspartate Receptor-Mediated Neurotoxicity.
Journal: ACS pharmacology & translational science
Published: March 31, 2025
Shaping Future Medicinal Chemists: Perspectives from European Schools of Pharmacy within the GP2A Network.
Journal: Journal of medicinal chemistry
Published: January 28, 2025
Multicomponent reactions driving the discovery and optimization of agents targeting central nervous system pathologies.
Journal: Beilstein journal of organic chemistry
Published: August 08, 2024
Discovery of N-substituted-2-((arylethyl)amino)-2-(2-methoxyphenyl) acetamides: A novel family of antiplatelet agents.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 07, 2024
N-Adamantyl-1-alkyl-4-oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as Fluorescent Probes to Detect Microglia Activation through the Imaging of Cannabinoid Receptor Subtype 2 (CB2R).
Journal: Journal of medicinal chemistry
Published: June 27, 2024
Exploring Biginelli-based scaffolds as A2B adenosine receptor antagonists: Unveiling novel structure-activity relationship trends, lead compounds, and potent colorectal anticancer agents.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 18, 2023
Progress on the development of Class A GPCR-biased ligands.
Journal: British journal of pharmacology
Published: December 11, 2023
Gemcitabine-Vitamin E Prodrug-Loaded Micelles for Pancreatic Cancer Therapy.
Journal: Pharmaceutics
Published: December 11, 2023
Last Updated: 09/26/2026